[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 2 of about 2
1. Nykky J, Tuusa JE, Kirjavainen S, Vuento M, Gilbert L: Mechanisms of cell death in canine parvovirus-infected cells provide intuitive insights to developing nanotools for medicine. Int J Nanomedicine; 2010;5:417-28
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mechanisms of cell death in canine parvovirus-infected cells provide intuitive insights to developing nanotools for medicine.
  • Viruses have great potential as nanotools in medicine for gene transfer, targeted gene delivery, and oncolytic cancer virotherapy.
  • Morphological studies of CPV-infected Norden laboratory feline kidney (NLFK) cells and canine fibroma cells (A72) displayed characteristic apoptotic events.
  • Apoptosis was further confirmed by activation of caspases and cellular DNA damage.
  • [MeSH-minor] Animals. Apoptosis. Caspases / metabolism. Cats. Cell Cycle. Cell Line. DNA Damage. DNA Fragmentation. Dogs. Flow Cytometry. Gene Expression. HeLa Cells. Humans. Membrane Potential, Mitochondrial. Microscopy, Electron, Transmission. Microscopy, Fluorescence. Nanomedicine. Necrosis. Viral Nonstructural Proteins / genetics

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virology. 2003 Nov 25;316(2):267-80 [14644609.001]
  • [Cites] Int J Cancer. 2004 Mar10;109(1):76-84 [14735471.001]
  • [Cites] J Virol. 2004 Jul;78(14):7775-83 [15220451.001]
  • [Cites] Exp Physiol. 2004 Jul;89(4):407-16 [15131072.001]
  • [Cites] J Cell Biol. 1973 Dec;59(3):766-71 [4128323.001]
  • [Cites] Adv Virus Res. 1987;33:91-174 [3296697.001]
  • [Cites] Virology. 1991 Jul;183(1):195-205 [1647068.001]
  • [Cites] J Virol. 1992 May;66(5):2821-8 [1560527.001]
  • [Cites] Blood. 1994 Sep 1;84(5):1415-20 [8068938.001]
  • [Cites] Am J Pathol. 1995 Jan;146(1):3-15 [7856735.001]
  • [Cites] J Virol. 1995 Aug;69(8):4702-10 [7609035.001]
  • [Cites] J Exp Med. 1995 Nov 1;182(5):1545-56 [7595224.001]
  • [Cites] J Immunol. 1996 Oct 1;157(7):3105-15 [8816421.001]
  • [Cites] J Virol. 1997 Feb;71(2):1386-96 [8995664.001]
  • [Cites] J Virol. 1998 Jan;72(1):802-6 [9420290.001]
  • [Cites] J Virol. 1998 Apr;72(4):3018-28 [9525624.001]
  • [Cites] J Virol. 1998 Jun;72(6):5224-30 [9573295.001]
  • [Cites] J Virol. 1998 Aug;72(8):6932-6 [9658149.001]
  • [Cites] Science. 1998 Aug 28;281(5381):1309-12 [9721092.001]
  • [Cites] J Virol. 1998 Nov;72(11):8893-903 [9765434.001]
  • [Cites] Virology. 1998 Oct 10;250(1):76-84 [9770422.001]
  • [Cites] Virology. 1998 Sep 30;249(2):440-52 [9791034.001]
  • [Cites] J Biol Chem. 1999 Jul 30;274(31):21953-62 [10419518.001]
  • [Cites] J Virol. 1999 Oct;73(10):8762-70 [10482630.001]
  • [Cites] J Virol. 2005 Feb;79(4):2274-86 [15681429.001]
  • [Cites] J Virol. 2006 Apr;80(8):4114-21 [16571827.001]
  • [Cites] Virology. 2006 Apr 10;347(2):379-91 [16430940.001]
  • [Cites] Mol Cell. 2006 Jul 7;23(1):121-32 [16818236.001]
  • [Cites] J Gen Virol. 2006 Sep;87(Pt 9):2539-48 [16894192.001]
  • [Cites] Cell Death Differ. 2007 Jan;14(1):32-43 [17082813.001]
  • [Cites] Int J Cancer. 2007 Mar 15;120(6):1364-71 [17154174.001]
  • [Cites] J Virol. 2007 Apr;81(8):4186-98 [17287256.001]
  • [Cites] Apoptosis. 2007 Jun;12(6):1069-83 [17245641.001]
  • [Cites] Apoptosis. 2007 Jun;12(6):1043-60 [17245642.001]
  • [Cites] Cell Death Differ. 2007 Jul;14(7):1237-43 [17431418.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12482-7 [17636126.001]
  • [Cites] J Virol. 2008 Mar;82(5):2241-9 [18077704.001]
  • [Cites] Methods. 2008 Mar;44(3):205-21 [18314051.001]
  • [Cites] Apoptosis. 2008 Apr;13(4):463-82 [18322800.001]
  • [Cites] Gene Ther. 2008 Jun;15(12):877-84 [18418413.001]
  • [Cites] Int J Cancer. 2008 Aug 1;123(3):493-9 [18500742.001]
  • [Cites] Exp Mol Pathol. 2008 Aug;85(1):2-10 [18514189.001]
  • [Cites] Arch Virol. 2008;153(8):1453-65 [18563285.001]
  • [Cites] Cancer Gene Ther. 2009 Feb;16(2):149-60 [18670452.001]
  • [Cites] Curr Top Microbiol Immunol. 2009;327:123-41 [19198573.001]
  • [Cites] Int J Cancer. 2010 Sep 1;127(5):1230-9 [20087864.001]
  • [Cites] Virus Res. 1999 Dec 15;65(2):161-74 [10581389.001]
  • [Cites] Brain Res Brain Res Protoc. 1999 Dec;4(3):335-40 [10592343.001]
  • [Cites] J Virol. 2000 Feb;74(4):1919-30 [10644365.001]
  • [Cites] J Biol Chem. 2000 Mar 31;275(13):9390-5 [10734083.001]
  • [Cites] Nat Cell Biol. 2000 Jun;2(6):318-25 [10854321.001]
  • [Cites] Microbiol Mol Biol Rev. 2000 Dec;64(4):821-46 [11104820.001]
  • [Cites] J Vet Med B Infect Dis Vet Public Health. 2000 Dec;47(10):775-84 [11204132.001]
  • [Cites] J Virol. 2001 Apr;75(8):3896-902 [11264378.001]
  • [Cites] J Virol. 2001 Apr;75(8):3965-70 [11264385.001]
  • [Cites] J Virol. 2001 Aug;75(16):7555-63 [11462027.001]
  • [Cites] Br J Haematol. 2001 Sep;114(3):574-80 [11552982.001]
  • [Cites] J Virol. 2001 Nov;75(22):11071-8 [11602746.001]
  • [Cites] Cell Death Differ. 2002 Jan;9(1):27-39 [11803372.001]
  • [Cites] Virology. 2002 Jan 20;292(2):224-34 [11878925.001]
  • [Cites] J Virol. 2002 May;76(9):4401-11 [11932407.001]
  • [Cites] J Cell Sci. 2003 Feb 1;116(Pt 3):525-36 [12508113.001]
  • [Cites] Nature. 2003 Jan 30;421(6922):499-506 [12556884.001]
  • [Cites] J Virol. 2003 Mar;77(5):2915-21 [12584315.001]
  • [Cites] J Virol. 2003 Jun;77(12):6683-91 [12767988.001]
  • [Cites] J Virol. 2003 Oct;77(19):10270-9 [12970411.001]
  • (PMID = 20957163.001).
  • [ISSN] 1178-2013
  • [Journal-full-title] International journal of nanomedicine
  • [ISO-abbreviation] Int J Nanomedicine
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] New Zealand
  • [Chemical-registry-number] 0 / NS1 protein, parvovirus; 0 / Viral Nonstructural Proteins; EC 3.4.22.- / Caspases
  • [Other-IDs] NLM/ PMC2950399
  • [Keywords] NOTNLM ; apoptosis / canine parvovirus / nanoparticle / necrosis / virotherapy
  •  go-up   go-down


Advertisement
2. Devouassoux-Shisheboran M, Schammel MD, Man YG, Tavassoli FA: Fibromatosis of the breast: age-correlated morphofunctional features of 33 cases. Arch Pathol Lab Med; 2000 Feb;124(2):276-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To predict if antiestrogenic agents are useful in the treatment of breast fibromatoses, we undertook an immunohistochemical study of sex steroid hormone receptors (estrogen receptor, progesterone receptor, and androgen receptor) and protein pS2 in 33 cases.
  • METHODS: The morphologic and immunohistochemical findings were correlated to patient menstrual status, which was categorized as childbearing age (n = 15), perimenopausal (n = 8), and postmenopausal (n = 10).
  • RESULTS: Fibromatoses in women of childbearing age were more cellular, more mitotically active, and displayed a larger proportion of cells with mild atypia than those in perimenopausal and postmenopausal women.
  • The hormonal status of these 3 groups does not explain the morphologic variations observed in these groups, inasmuch as no immunostaining for any of the hormone receptors was detected in the tumors.
  • CONCLUSIONS: The absence of estrogen receptor and pS2 in breast fibromatoses suggests that antiestrogenic agents are unlikely to be beneficial in the management of these tumors.
  • [MeSH-major] Breast Neoplasms / pathology. Fibroma / pathology
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Female. Humans. Immunohistochemistry. Ki-67 Antigen / analysis. Middle Aged. Postmenopause. Premenopause. Proteins / analysis. Receptors, Androgen / analysis. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis. Tumor Suppressor Proteins

  • Genetic Alliance. consumer health - Fibromatosis.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10656738.001).
  • [ISSN] 0003-9985
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Proteins; 0 / Receptors, Androgen; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; 0 / TFF1 protein, human; 0 / Tumor Suppressor Proteins
  •  go-up   go-down






Advertisement